COMMUNIQUÉ DE PRESSE publié le 25/01/2024 à 09:01, il y a 9 mois 27 jours Original-Research: MLP SE (von NuWays AG): BUY This research report from NuWays AG provides a strong recommendation to BUY MLP SE stocks, with a price target of €11.00 over the next 12 months. The report highlights MLP's strong diversification across business segments, solid profitability projection, tailwinds from new interest rate trends, potential for highly profitable performance fees, and the unlikely downside from the real estate business. The report emphasizes the unjustified valuation of MLP shares, trading at historically low multiples, and recommends adding MLP to NuWays' Alpha List 2024. MLP SE Stock NuWays AG Research Investment Recommendation Financial Analysis Stock Valuation
COMMUNIQUÉ DE PRESSE publié le 10/11/2023 à 10:01, il y a 1 année Original-Research: MLP SE (von NuWays AG): BUY
COMMUNIQUÉ DE PRESSE publié le 09/11/2023 à 07:31, il y a 1 année MLP SE: '9M: Total revenue hits new record level'
COMMUNIQUÉ DE PRESSE publié le 10/08/2023 à 07:32, il y a 1 année 3 mois MLP SE: H1: MLP holds its ground in an environment that remains difficult
COMMUNIQUÉ DE PRESSE publié le 17/05/2023 à 17:37, il y a 1 année 6 mois MLP SE: Invitation to the Annual General Meeting of MLP SE published
COMMUNIQUÉ DE PRESSE publié le 11/05/2023 à 07:33, il y a 1 année 6 mois MLP SE: Q1: MLP remains on course
COMMUNIQUÉ DE PRESSE publié le 09/03/2023 à 07:31, il y a 1 année 8 mois MLP SE: FY 2022: MLP defies difficult environment – 2025 growth course reaffirmed
Publié le 21/11/2024 à 06:58, il y a 7 heures 3 minutes Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Publié le 21/11/2024 à 06:58, il y a 7 heures 3 minutes Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Publié le 21/11/2024 à 06:58, il y a 7 heures 3 minutes Netto-actiefwaarde per aandeel stijgt in zes maanden met 9,4% tot EUR 55,6 dankzij aanhoudend sterke groeiprestaties van portefeuille
Publié le 20/11/2024 à 20:07, il y a 17 heures 53 minutes Entech : Nouveaux objectifs stratégiques à moyen-terme et Chiffre d’Affaires du 1er semestre 2024
Publié le 20/11/2024 à 19:20, il y a 18 heures 41 minutes Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Publié le 21/11/2024 à 13:30, il y a 31 minutes AirIQ Announces September 30, 2024 Quarterly Results Company Reports Double-Digit Growth in Recurring Revenue
Publié le 21/11/2024 à 13:30, il y a 31 minutes Datametrex Secures Additional P.O. Approx $250K for IT Services
Publié le 21/11/2024 à 13:00, il y a 1 heure 1 minute Aclara Secures Funding from Corfo's Innovation High-Tech Program for Artificial Intelligence Project
Publié le 21/11/2024 à 13:00, il y a 1 heure 1 minute Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1
Publié le 21/11/2024 à 13:00, il y a 1 heure 1 minute Toggle3D.ai Rebrands as FOTOgpt.ai to Usher in a New Age of AI-Powered Photography
Publié le 21/11/2024 à 13:41, il y a 19 minutes Original-Research: Pentixapharm Holding AG (von BankM AG): Kaufen
Publié le 21/11/2024 à 12:35, il y a 1 heure 25 minutes audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Publié le 21/11/2024 à 12:15, il y a 1 heure 45 minutes Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven